Orthocell (OCC.AX) Earnings Analysis
Orthocell (OCC.AX) next reports earnings on 2026-08-28. Trailing P/E -14.05.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OCC.AX next report earnings?
| Next earnings date | 2026-08-28 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.00B |
OCC.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-23 | -0.021 AUD | n/a | n/a | n/a |
| 2025-02-21 | -0.006 AUD | n/a | n/a | n/a |
| 2024-10-17 | -0.00962 AUD | n/a | n/a | n/a |
OCC.AX valuation and analyst view
| Trailing P/E | -14.05 |
|---|---|
| Trailing EPS | -0.05029 AUD |
| Price / book | 4.31 |
| Dividend yield | 0.00% |
| Market cap | 0.16B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Orthocell (OCC.AX)'s next earnings date?
Orthocell is next scheduled to report on 2026-08-28 and revenue estimate of 0.00B.
Did OCC.AX beat earnings last quarter?
Consensus estimate data was not available for OCC.AX's 2026-02-23 report.
What is OCC.AX's current P/E ratio and EPS?
OCC.AX trades at a trailing P/E of -14.05 on trailing EPS of -0.05028853734743111 AUD.
What do analysts rate OCC.AX?
OCC.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.